ABPM	ambulatory blood pressure monitoring
ACEi	angiotensin-converting enzyme inhibitor
ACR	albumin-to-creatinine ratio
ADPKD	autosomal dominant polycystic kidney disease
AKI	acute kidney injury
ARB	angiotensin receptor blocker
BP	blood pressure
CGA	cause, glomerular filtration rate, and albuminuria
CKD	chronic kidney disease
CKD-EPI	Chronic Kidney Disease Epidemiology Collaboration
CV	cardiovascular
DKD	diabetic kidney disease
eGFR	estimated glomerular filtration rate
ESKD	end-stage kidney disease
FAS	full age spectrum
FLC	free light chains
RFR	renal functional reserve
GBM	glomerular basement membrane
GFR	glomerular filtration rate
HF	heart failure
IgA	immunoglobulin A
KDIGO	Kidney Disease: Improving Global Outcomes
LMW	low molecular weight
mGFR	measured glomerular filtration rate
MRA	mineralocorticoid receptor antagonist
ns-MRA	non-steroidal mineralocorticoid receptor antagonist
RAAS	renin–angiotensin–aldosterone system
RAASi	renin–angiotensin–aldosterone system inhibitor
RCT	randomized controlled trial
SBP	systolic blood pressure
SGLT2	sodium–glucose cotransporter 2
SGLT2i	sodium–glucose cotransporter 2 inhibitor
T1D	type 1 diabetes
T2D	type 2 diabetes
TGF	tubuloglomerular feedback
UACR	urinary albumin-to-creatinine ratio
UPCR	urinary protein-to-creatinine ratio
β2-MG	beta-2 microglobulin